These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 24306658

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation.
    Drebber U, Baldus SE, Nolden B, Grass G, Bollschweiler E, Dienes HP, Hölscher AH, Mönig SP.
    Oncol Rep; 2008 Jun; 19(6):1477-83. PubMed ID: 18497953
    [Abstract] [Full Text] [Related]

  • 4. Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma.
    Ke AW, Shi GM, Zhou J, Wu FZ, Ding ZB, Hu MY, Xu Y, Song ZJ, Wang ZJ, Wu JC, Bai DS, Li JC, Liu KD, Fan J.
    Hepatology; 2009 Feb; 49(2):491-503. PubMed ID: 19065669
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
    Zheng HC, Takahashi H, Li XH, Hara T, Masuda S, Guan YF, Takano Y.
    Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas.
    Lee D, Suh YL, Park TI, Do IG, Seol HJ, Nam DH, Kim ST.
    J Surg Oncol; 2013 May; 107(6):646-52. PubMed ID: 22926763
    [Abstract] [Full Text] [Related]

  • 7. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery.
    Wen Y, Wang Q, Zhou C, Yan D, Qiu G, Yang C, Tang H, Peng Z.
    Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347
    [Abstract] [Full Text] [Related]

  • 8. The Prognostic Significance of c-MET and EGFR Overexpression in Resected Gastric Adenocarcinomas.
    Paliga A, Marginean H, Tessier-Cloutier B, Purgina B, Jonker D, Marginean EC.
    Am J Clin Oncol; 2017 Dec; 40(6):543-551. PubMed ID: 26125303
    [Abstract] [Full Text] [Related]

  • 9. Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma.
    Nagatsuma AK, Aizawa M, Kuwata T, Doi T, Ohtsu A, Fujii H, Ochiai A.
    Gastric Cancer; 2015 Apr; 18(2):227-38. PubMed ID: 24626858
    [Abstract] [Full Text] [Related]

  • 10. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
    Wang JY, Hsieh JS, Chen CC, Tzou WS, Cheng TL, Chen FM, Huang TJ, Huang YS, Huang SY, Yang T, Lin SR.
    J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C, Wen Y, Li H, Zhang D, Zhang N, Shi X, Jiang B, Ma X, Yang P, Tang H, Peng Z, Yang Y.
    Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
    [Abstract] [Full Text] [Related]

  • 12. Reduced Krüppel-like factor 17 (KLF17) expression correlates with poor survival in patients with gastric cancer.
    Peng JJ, Wu B, Xiao XB, Shao YS, Feng Y, Yin MX.
    Arch Med Res; 2014 Jul; 45(5):394-9. PubMed ID: 24947617
    [Abstract] [Full Text] [Related]

  • 13. Comparative analysis of protein expressions in primary and metastatic gastric carcinomas.
    Kim JH, Kim MA, Lee HS, Kim WH.
    Hum Pathol; 2009 Mar; 40(3):314-22. PubMed ID: 18835621
    [Abstract] [Full Text] [Related]

  • 14. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z, Cai SR, He YL, Zhan WH, Chen CQ, Cui J, Wu WH, Wu H, Song W, Zhang CH, Peng JJ, Huang XH.
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer.
    Ito T, Yamada S, Tanaka C, Ito S, Murai T, Kobayashi D, Fujii T, Nakayama G, Sugimoto H, Koike M, Nomoto S, Fujiwara M, Kodera Y.
    Ann Surg Oncol; 2014 Feb; 21(2):560-8. PubMed ID: 24046108
    [Abstract] [Full Text] [Related]

  • 16. Prognostic role of p-mTOR expression in cancer tissues and metastatic lymph nodes in pT2b gastric cancer.
    An JY, Kim KM, Choi MG, Noh JH, Sohn TS, Bae JM, Kim S.
    Int J Cancer; 2010 Jun 15; 126(12):2904-13. PubMed ID: 19739122
    [Abstract] [Full Text] [Related]

  • 17. Erythropoietin-Producing Hepatocellular A1 is an Independent Prognostic Factor for Gastric Cancer.
    Nakagawa M, Inokuchi M, Takagi Y, Kato K, Sugita H, Otsuki S, Kojima K, Uetake H, Sugihara K.
    Ann Surg Oncol; 2015 Jul 15; 22(7):2329-35. PubMed ID: 25391265
    [Abstract] [Full Text] [Related]

  • 18. Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer.
    Santini D, Vincenzi B, Fratto ME, Perrone G, Lai R, Catalano V, Cass C, Ruffini PA, Spoto C, Muretto P, Rizzo S, Muda AO, Mackey JR, Russo A, Tonini G, Graziano F.
    J Cell Physiol; 2010 May 15; 223(2):384-8. PubMed ID: 20082300
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.